Form 4: Mustang Bio CEO Manuel Litchman Reports Stock Transaction

CEO Manuel Litchman reports relinquishing shares to cover tax liabilities and acquiring shares through the Employee Stock Purchase Plan.

Summary

• On May 31, 2024, Manuel Litchman, the President and CEO of Mustang Bio, Inc., relinquished 1,396 shares of common stock to cover tax liabilities associated with the vesting of restricted stock units.
• The price per share for the transaction was $0.35.
• Following the transaction, Litchman directly owns 83,024 shares of Mustang Bio, Inc.
• This includes 5,000 shares acquired under the Mustang Bio, Inc. Employee Stock Purchase Plan on March 1, 2024.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions. The relinquishing of shares to cover tax liabilities is neutral, while participation in the employee stock purchase plan is a mildly positive signal.

Positives

• The CEO's participation in the Employee Stock Purchase Plan indicates confidence in the company's future.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the change in ownership by a key executive.

Key Dates

Keywords

Mustang Bio, MBIO, Manuel Litchman, Stock Transaction, Form 4, SEC Filing, Insider Trading, Employee Stock Purchase Plan, Restricted Stock Units, Tax Liability